Dokter Terapi target di Luar Negeri — Halaman 3

Berspesialisasi dalam prosedur endoskopi tingkat lanjut, Dr. Erdogan membawa keahlian dalam ERCP (Cholangiopancreatography Retrograde Endoscopic), EUS (Endoscopic Ultrasound), dan pengobatan IBD (Inflammatory Bowel Disease) di Rumah Sakit Liv Universitas İstinye Topkapı.

• Program fellowship klinis dalam gastroenterologi di Rumah Sakit Kota Ankara
• Menerbitkan berbagai artikel penelitian tentang pengobatan penyakit radang usus
• Berpengalaman dalam miotomi endoskopi peroral (POEM) dan diseksi submukosa endoskopi (ESD)
• Kontributor aktif untuk jurnal peer-review di bidang gastroenterologi

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Lucía González Cortijo is the Head of Medical Oncology at Hospital Universitario Quirónsalud Madrid. She specializes in breast and gynecologic cancers, including ovarian and cervical malignancies. Dr. González Cortijo holds a PhD cum laude and a Master’s in Molecular Oncology. She focuses on precision oncology, immunotherapy, and targeted treatments.

• Principal Investigator in over 20 Phase II–III clinical trials.
• Participated as a sub-investigator in more than 50 international trials.
• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Founder of the La Vida en Rosa Foundation for women with cancer.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Direktur Klinis Unit Payudara Multidisiplin di Kliniken Essen-Mitte – Sherko Kuemmel memimpin penelitian dan pengobatan kanker payudara tingkat lanjut.

• 322 publikasi peer-review tentang kanker payudara
• Anggota Dewan Eksekutif AGO – menyusun pedoman kanker payudara
• Memimpin uji klinis internasional sebagai Global PI
• Anggota Fakultas ESMO untuk edukasi kanker payudara

Kepala Dokter Pusat Onkologi di Assuta Medical Center – ahli terkemuka dalam terapi target.

• Berspesialisasi dalam perawatan onkologi presisi
• Pengalaman luas dengan terapi kanker personalisasi
• Bekerja di salah satu pusat kanker terbaik di Israel

Prof. Elke Jaeger adalah spesialis sarkoma terkemuka dan salah satu ahli onkologi terbaik di Jerman, menurut peringkat Focus.

• Lebih dari 35 tahun praktik di bidang onkologi dan hematologi
• Kepala Onkologi dan Hematologi di Klinik Nordwest
• Berspesialisasi dalam terapi bertarget untuk kasus-kasus kompleks

Dr. Eckhart Weidemann memimpin sektor Hematologi di Klinik Nordwest – seorang spesialis dalam pengobatan kelainan darah dengan pengalaman lebih dari 30 tahun.

• Berspesialisasi dalam kasus limfoma non-Hodgkin
• Memimpin bidang hematologi di Klinik Nordwest
• Profesor dengan latar belakang akademis yang luas

Prof. Dr. Abdullah Sakin is a Professor of Medical Oncology specializing in the diagnosis and treatment of solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecological, and head and neck cancers, as well as malignant melanoma. He provides personalized cancer care using advanced treatment approaches such as chemotherapy, targeted therapies, immunotherapy, hormone therapy, and precision oncology. With more than 200 scientific publications and active involvement in international clinical research, he is committed to delivering evidence-based, patient-centered cancer care. 


 

Dr. Borde telah menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid di HCG Manavata Cancer Centre.

• 12 tahun pengalaman dalam kedokteran nuklir
• Berspesialisasi dalam terapi radioiodin & Lu-177 RN
• Mahir dalam semua jenis pemindaian nuklir dan PET-CT
• Penelitian yang dipublikasikan dalam jurnal medis

35 tahun berspesialisasi dalam kehamilan berisiko tinggi – Dr. Vatsa menangani kasus-kasus kompleks di Fortis Memorial Research Institute.

• Ahli dalam bedah endoskopi dan metode diagnostik
• Berspesialisasi dalam penanganan kehamilan ektopik dan keguguran
• Penulis berbagai artikel tentang onkoginekologi
• Anggota Asosiasi Ginekolog India